Free Trial
OTCMKTS:SMMNY

Siemens Healthineers 11/6/2024 Earnings Report

Siemens Healthineers logo
$27.01 +0.26 (+0.97%)
As of 03:59 PM Eastern

Siemens Healthineers EPS Results

Actual EPS
$0.37
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Siemens Healthineers Revenue Results

Actual Revenue
$6.96 billion
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Siemens Healthineers Announcement Details

Quarter
Time
Before Market Opens
Conference Call Date
N/A
Conference Call Time
N/A

Upcoming Earnings

Siemens Healthineers' next earnings date is estimated for Wednesday, July 30, 2025, based on past reporting schedules.

Conference Call Resources

Siemens Healthineers Earnings Headlines

INVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting Off
Right now, we’re witnessing a monumental shift in the world.
SMMNY Siemens Healthineers AG - Seeking Alpha
See More Siemens Healthineers Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Siemens Healthineers? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Siemens Healthineers and other key companies, straight to your email.

About Siemens Healthineers

Siemens Healthineers (OTCMKTS:SMMNY) is a global medical technology company specializing in diagnostic and therapeutic imaging, laboratory diagnostics, and advanced healthcare IT solutions. Established as an independent entity in 2018 following its spin-off from Siemens AG, the company traces its roots back to the pioneering work of Werner von Siemens in the mid-19th century. Today, it offers a comprehensive portfolio of products and services designed to support healthcare providers in diagnosing, treating, and monitoring patients across a wide range of clinical settings.

The company’s imaging business delivers systems and solutions in fields such as magnetic resonance imaging (MRI), computed tomography (CT), X-ray, ultrasound and molecular imaging. In laboratory diagnostics, Siemens Healthineers provides instruments and assays for immunoassay, clinical chemistry, hematology and point-of-care testing. Its advanced therapy offerings include robotic-assisted interventions and image-guided therapies, enabling minimally invasive treatments in cardiology, oncology and vascular surgery. Complementing these core businesses are extensive service and maintenance contracts, training programs and consulting services aimed at maximizing equipment uptime and clinical workflow efficiency.

Siemens Healthineers serves healthcare institutions in more than 70 countries across Europe, the Americas, Asia and other regions. The company has made significant investments in digitalization and artificial intelligence, launching platforms such as AI-enabled diagnostic software, telehealth solutions and cloud-based data analytics tools. These innovations are intended to enhance diagnostic accuracy, optimize treatment planning and improve operational performance in hospitals and laboratories. Through research collaborations with academic centers and partnerships with technology firms, Siemens Healthineers continues to expand its digital ecosystem to address evolving healthcare challenges.

Led by Chief Executive Officer Dr. Bernd Montag, Siemens Healthineers employs a management team with deep expertise in healthcare, engineering and life sciences. The company remains committed to its founding principle of combining technological innovation with clinical insight to advance patient care. With a focus on sustainability and social responsibility, Siemens Healthineers pursues initiatives aimed at reducing environmental impact, improving access to quality diagnostics and therapies, and fostering diversity and inclusion within its global workforce.

View Siemens Healthineers Profile

More Earnings Resources from MarketBeat